医学
眼科
眼睑
四分位间距
睑板腺
黄斑变性
外科
作者
Agni Malmin,Vilde M. Thomseth,Per Tore Førland,Ayyad Zartasht Khan,Hanne Brit Hetland,Xiangjun Chen,Inga-Britt K. Haugen,Tor Paaske Utheim,Vegard A. Forsaa
出处
期刊:Ophthalmology
[Elsevier BV]
日期:2023-01-21
卷期号:130 (5): 509-515
被引量:13
标识
DOI:10.1016/j.ophtha.2023.01.009
摘要
PurposeTo investigate the effects of serial intravitreal injections (IVI) on the ocular surface and meibomian glands (MG) in patients treated with anti-vascular endothelial growth factor (anti-VEGF) for neovascular age-related macular degeneration (nAMD).DesignRetrospective controlled observational study.SubjectsPatients with nAMD receiving unilateral IVI with anti-VEGF agents. The fellow eye was used as control.MethodsTear film and ocular surface examinations were performed on a single occasion at a minimum of four weeks after IVI. A pre-IVI asepsis protocol with povidone-iodine was applied.Main Outcome MeasuresUpper and lower MG loss, tear meniscus height (TMH), bulbar redness score (BR), non-invasive tear break-up time (NIBUT), tear film osmolarity (TOsm), Schirmer test, corneal staining, fluorescein tear film break-up time (TBUT), meibomian gland expressibility (ME) and meibum quality (MQ).ResultsNinety patients with a mean age of 77.5 years (SD 8.4; range 54-95) were included. The median number of IVI in treated eyes was 19.5 (range 2–132). Mean MG loss in the upper eyelid was 19.1 (SD 11.3) % in treated eyes and 25.5 (SD 14.6) % in untreated fellow eyes (P=0.001). For the lower eyelid, median MG loss was 17.4 (IQR 9.4-29.9) % in treated eyes and 24.5 (IQR 14.2-35.2) % in fellow eyes (P<0.001). Mean BR was 1.32 (SD 0.46) in treated eyes versus 1.44 (SD 0.45) in fellow eyes (P=0.017). Median TMH was 0.36 (IQR 0.28-0.52) mm in treated eyes and 0.32 (IQR 0.24-0.49) mm in fellow eyes (P=0.02). There were no differences between treated and fellow eyes regarding NIBUT, TOsm, Schirmer test, corneal staining, fluorescein TBUT, meibomian gland expressibility ME or MQ.ConclusionsRepeated IVI with anti-VEGF with preoperative povidone-iodine application was associated with reduced meibomian gland loss, increased tear volume and reduced signs of inflammation compared to fellow non-treated eyes in patients with nAMD. This regimen may thus have a beneficial effect on the ocular surface.
科研通智能强力驱动
Strongly Powered by AbleSci AI